Box Office Paradox: How Jessica Chastain’s Panned Horror Film ‘Other Mommy’ Is Charging Past $100 Million
By Rohan Naahar
Published October 27, 2026
Main Facts: A Commercial Juggernaut Defies Critical Consensus
In the modern landscape of cinema, the correlation between critical acclaim and commercial success is frequently complicated, but few 2026 releases have embodied this disconnect as starkly as Universal Pictures’ horror-thriller Other Mommy.
Starring Academy Award winner Jessica Chastain and directed by genre filmmaker Rob Savage, the feature has proven to be an unstoppable box-office force despite being soundly rejected by critics. Produced on a modest budget of under $20 million, the film is hurtling toward the coveted $100 million global milestone as it enters its third week of theatrical release.
Domestically, Other Mommy has amassed an impressive $50 million, supported by an international haul that brings its current worldwide gross to approximately $95 million. This financial trajectory places it firmly in the black, ensuring profitability for Universal Pictures long before its inevitable transition to premium video-on-demand (PVOD) platforms.
Yet, this commercial triumph stands in stark contrast to its critical reception. The film holds a dismal 20% approval rating on the review aggregator Rotten Tomatoes. The site’s official critics’ consensus reads:
"Despite a valiant turn from Jessica Chastain as the spectral embodiment of a smothering parent, ‘Other Mommy’ proves too silly for its intermittently effective jump scares to add up to a spooky whole."
Despite the scathing reviews, audiences have turned out in droves, proving once again that high-concept horror—particularly when anchored by a recognizable movie star—possesses a unique immunity to negative critical consensus.
Chronology: From a Strong Opening to Theatrical Retrenchment
The journey of Other Mommy to the edge of the $100 million threshold has been a fast-paced exercise in theatrical endurance.
Week One: Defying the Critics
Released on October 9, 2026, the film entered the domestic market facing intense skepticism from trade analysts due to its lack of franchise pedigree and poor early review embargo drops. However, counter-programming instincts paid off for Universal. Other Mommy debuted with a stellar $27 million domestic opening weekend, comfortably securing a prominent place in the box-office top ten and outperforming expectations.
Week Two: Holding the Line
During its second frame, the film demonstrated respectable legs, holding onto a significant portion of its audience despite heavy word-of-mouth chatter regarding its narrative shortcomings. While typical horror fare often experiences steep 60% to 70% drops in its second weekend, Other Mommy maintained enough steam to cross the $40 million domestic mark by day fourteen.
Week Three: Facing New Competition and Theater Reductions
As it entered its third weekend, the film encountered its stiffest hurdle yet: a wave of fresh competition, most notably the arrival of DC Studios’ Clayface, which dominated the box office with a $24 million number-one debut. Sensing the shifting marketplace, exhibitors began adjusting screen allocations. Other Mommy saw its domestic theater footprint reduced from approximately 3,300 locations down to roughly 2,800. Nevertheless, the film retained a spot in the domestic top ten, pushing its cumulative domestic earnings to $50 million and setting the stage for its global milestone.
Supporting Data: Box Office Comparisons and Genre Context
To fully understand the financial footprint of Other Mommy, one must examine its performance relative to other 2026 horror releases and Jessica Chastain’s broader filmography.
2026 Horror Landscape
The horror genre has experienced a mixed box-office year, but Other Mommy has quietly out-grossed several high-profile genre competitors released earlier in the calendar year. It has surpassed the total theatrical yields of:
- Evil Dead Burn
- Lee Cronin’s The Mummy
- Send Help
Director Rob Savage’s Trajectory
For director Rob Savage, Other Mommy represents a significant commercial escalation. Savage first broke into the cultural consciousness with pandemic-era micro-budget hits Host (2020) and Dashcam (2021), both released during a time when traditional theatrical distribution was paralyzed.
Transitioning to Hollywood studio filmmaking, Savage directed 2023’s The Boogeyman, which grossed over $80 million worldwide. With Other Mommy, Savage has officially out-grossed The Boogeyman’s lifetime global haul in under three weeks of release, cementing his status as a bankable studio horror director capable of delivering high return-on-investment (ROI) metrics.
Jessica Chastain’s Horror Pedigree
Jessica Chastain is no stranger to the horror genre, though her past entries have enjoyed varying degrees of critical favor.
- Mama (2013): Directed by Andy Muschietti, this supernatural thriller opened to strong commercial numbers and finished with a lifetime global haul of $148 million. While Other Mommy is unlikely to match Mama‘s ultimate global total, it is tracking comfortably ahead of many standard mid-budget horror releases.
- It Chapter Two (2019): In which Chastain played the adult Beverly Marsh, grossing over $470 million worldwide as part of a massive Warner Bros. tentpole franchise.
While Other Mommy won’t touch the box-office heights of It Chapter Two, its profitability profile on a sub-$20 million budget makes it a quiet financial win for Universal.
Official Responses and Industry Reactions
The commercial success of Other Mommy has reignited industry discussions regarding the widening chasm between film critics and general ticket-buyers. Studio executives at Universal Pictures have remained pragmatic about the film’s performance, recognizing that high-concept supernatural thrillers targeted at young adult and horror-fan demographics frequently rely on atmospheric trailers, jump-scare compilations on social media, and star power rather than critical endorsements.
Jessica Chastain has consistently defended her choice of material, emphasizing in past press tours that genre cinema allows for transgressive, emotionally raw storytelling that doesn’t always adhere to conventional narrative neatness. Meanwhile, director Rob Savage has leaned into the film’s sensationalized elements, noting in social media posts that the movie was expressly designed to evoke roller-coaster-style thrills rather than high-art solemnity.
Exhibitors have also weighed in on the film’s theater retention. Even with the reduction of 500 screens in its third weekend, theater owners noted that Other Mommy continued to pull in steady walk-up traffic from demographics unconcerned with Rotten Tomatoes scores—particularly younger audiences seeking weekend date-night entertainment.
Implications: What Other Mommy Means for the Future of Mid-Budget Horror
The trajectory of Other Mommy carries several important implications for the business of Hollywood horror and theatrical distribution:
1. The Bulletproof Nature of Mid-Budget Horror
At a time when major blockbusters require astronomical budgets and massive global box-office grosses simply to break even, mid-budget horror remains the most reliable financial engine in Hollywood. By keeping production costs below $20 million, Universal ensured that Other Mommy only needed a modest opening weekend to cover its production and domestic marketing expenditures. Reaching $100 million worldwide transforms a critically panned film into a highly lucrative asset.
2. The Power of Star-Driven Genre Vehicles
While modern horror often relies on high-concept premises or viral marketing (such as original indie breakouts), the inclusion of an A-list star like Jessica Chastain provides an invaluable floor for opening-weekend attendance. Even when word-of-mouth or critical reviews turn sour, a recognizable face on the poster serves as an institutional anchor that drives curious moviegoers into theaters during the crucial first ten days of release.
3. The PVOD Pipeline
The speedy transition of profitable horror titles to PVOD platforms has become standard operating procedure for studios. Having capitalized on the theatrical window—pushing past the $95 million global mark and clearing the theater-retrenchment hurdle—Other Mommy is positioned to perform exceptionally well once it hits digital rental and purchase storefronts. Horror fans who chose to skip the theatrical run due to poor reviews are frequently willing to stream these titles at home on a weekend evening, providing a second profitable revenue stream for the studio.
Ultimately, Other Mommy serves as a textbook reminder that the box office operates on its own terms. While critics may dismiss the film as a formulaic exercise in jump scares, the global moviegoing public has spoken with their wallets—guaranteeing that Rob Savage and Jessica Chastain’s supernatural thriller will secure its place in the black before winding down its theatrical run.
